Bio-Rad Laboratories Stock Forecast
NYSE: BIOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
BIO analyst consensus
Consensus (3 analysts)
hold
Avg. price target
$328.33-8.90%
- Strong buy 1
- Buy 0
- Hold 1
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 3 Wall Street analysts covering Bio-Rad Laboratories (2026-10-07), 1 rate the stock a buy or strong buy, 1 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $328.33, with a high estimate of $390.00 and a low estimate of $280.00. The average target implies downside of 8.9% from the current price of $360.40.
The spread between the highest and lowest targets is 39.3%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for BIO.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 33% |
| Buy | 0 | 0% |
| Hold | 1 | 33% |
| Sell | 0 | 0% |
| Strong sell | 1 | 33% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $280.00 | -22.31% |
| Average target | $328.33 | -8.90% |
| High target | $390.00 | +8.21% |